Lantheus Holdings (NASDAQ:LNTH) Receives News Sentiment Rating of 0.29
Media headlines about Lantheus Holdings (NASDAQ:LNTH) have trended positive on Monday, according to Accern Sentiment. Accern rates the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Lantheus Holdings earned a news sentiment score of 0.29 on Accern’s scale. Accern also gave headlines about the medical equipment provider an impact score of 47.250792057642 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
These are some of the headlines that may have effected Accern Sentiment Analysis’s scoring:
- GoFundMe Account Set Up For School Explosion Victims (naijaoversabi.com)
- Financial Comparison: Lantheus Holdings (NASDAQ:LNTH) and Biocept (BIOC) (americanbankingnews.com)
- Q3 2017 Earnings Estimate for Lantheus Holdings, Inc. Issued By Jefferies Group (NASDAQ:LNTH) (americanbankingnews.com)
- Samsung Galaxy J7 Pro now available in India (naijaoversabi.com)
- Lantheus Holdings, Inc. breached its 50 day moving average in a Bearish Manner : LNTH-US : August 3, 2017 (finance.yahoo.com)
A number of research analysts recently weighed in on the company. Jefferies Group LLC boosted their price objective on Lantheus Holdings from $15.00 to $18.00 and gave the stock a “buy” rating in a report on Wednesday, May 3rd. Zacks Investment Research lowered Lantheus Holdings from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 5th. Credit Suisse Group boosted their price objective on Lantheus Holdings from $14.00 to $19.00 and gave the stock a “neutral” rating in a report on Wednesday, August 2nd. Finally, Cantor Fitzgerald assumed coverage on Lantheus Holdings in a report on Monday, July 17th. They set an “overweight” rating and a $22.00 price objective for the company. One equities research analyst has rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $18.60.
Shares of Lantheus Holdings (LNTH) traded up 9.59% during trading on Monday, reaching $18.85. The company’s stock had a trading volume of 742,330 shares. The company has a market capitalization of $704.05 million, a price-to-earnings ratio of 25.75 and a beta of 0.91. The firm’s 50-day moving average price is $17.48 and its 200-day moving average price is $13.82. Lantheus Holdings has a one year low of $4.20 and a one year high of $20.40.
Lantheus Holdings (NASDAQ:LNTH) last issued its earnings results on Tuesday, August 1st. The medical equipment provider reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.18. Lantheus Holdings had a net margin of 8.44% and a negative return on equity of 37.47%. The company had revenue of $88.83 million for the quarter, compared to the consensus estimate of $80.56 million. During the same period in the previous year, the firm earned $0.24 earnings per share. Lantheus Holdings’s quarterly revenue was up 13.9% compared to the same quarter last year. On average, equities analysts anticipate that Lantheus Holdings will post $0.93 earnings per share for the current year.
In related news, CEO Mary Anne Heino sold 10,000 shares of Lantheus Holdings stock in a transaction that occurred on Monday, June 12th. The shares were sold at an average price of $15.39, for a total value of $153,900.00. Following the completion of the transaction, the chief executive officer now owns 602,468 shares in the company, valued at $9,271,982.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Michael P. Duffy sold 20,000 shares of Lantheus Holdings stock in a transaction that occurred on Monday, June 12th. The shares were sold at an average price of $15.42, for a total transaction of $308,400.00. Following the completion of the transaction, the insider now owns 188,234 shares of the company’s stock, valued at approximately $2,902,568.28. The disclosure for this sale can be found here. Insiders sold a total of 6,060,000 shares of company stock worth $85,757,800 over the last three months. Insiders own 2.30% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Lantheus Holdings (NASDAQ:LNTH) Receives News Sentiment Rating of 0.29” was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The legal version of this article can be accessed at https://www.dailypolitical.com/2017/08/07/lantheus-holdings-nasdaqlnth-receives-news-sentiment-rating-of-0-29.html.
Lantheus Holdings Company Profile
Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.
Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.